Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy.

Chowdhary M, Patel KR, Danish HH, Lawson DH, Khan MK.

Onco Targets Ther. 2016 Dec 12;9:7149-7159. doi: 10.2147/OTT.S119428. eCollection 2016. Review.

2.

The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis.

Danish HH, Patel KR, Switchenko JM, Gillespie TW, Jhaveri J, Chowdhary M, Abugideiri M, Delman KA, Lawson DH, Khan MK.

Melanoma Res. 2016 Dec;26(6):595-603.

3.

BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis.

Patel KR, Chowdhary M, Switchenko JM, Kudchadkar R, Lawson DH, Cassidy RJ, Prabhu RS, Khan MK.

Melanoma Res. 2016 Aug;26(4):387-94. doi: 10.1097/CMR.0000000000000268.

4.

CD30+ Cutaneous T Cell Lymphoma: Response to Rotational Total Skin Electron Irradiation.

Danish HH, Heumann TR, Bradley KT, Switchenko J, Esiashvili N, Lechowicz MJ, Flowers CR, Khan MK.

Dermatol Ther (Heidelb). 2016 Jun;6(2):251-63. doi: 10.1007/s13555-016-0115-8. Epub 2016 Apr 16.

5.

Surgical management of gastric cancer: Single center experience from a developing country.

Khan MK, Syed AA, Khattak S, Kazmi SA, Yusuf A.

South Asian J Cancer. 2015 Jul-Sep;4(3):127-9. doi: 10.4103/2278-330X.173169.

6.

The role of radiotherapy for patients over age 60 with diffuse large B-cell lymphoma in the rituximab era.

Cassidy RJ, Jegadeesh N, Switchenko J, Danish H, Esiashvili N, Flowers CR, Khan MK.

Leuk Lymphoma. 2016 Aug;57(8):1876-82. doi: 10.3109/10428194.2015.1120866. Epub 2016 Jan 12.

7.

The role of repetition and reinforcement in school-based oral health education-a cluster randomized controlled trial.

Haleem A, Khan MK, Sufia S, Chaudhry S, Siddiqui MI, Khan AA.

BMC Public Health. 2016 Jan 4;16:2. doi: 10.1186/s12889-015-2676-3.

8.

Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma.

Oliver DE, Patel KR, Switchenko J, Parker D, Lawson DH, Delman KA, Kudchadkar RR, Khan MK.

Melanoma Res. 2016 Feb;26(1):35-41. doi: 10.1097/CMR.0000000000000201.

9.

Potential protective properties of flax lignan secoisolariciresinol diglucoside.

Imran M, Ahmad N, Anjum FM, Khan MK, Mushtaq Z, Nadeem M, Hussain S.

Nutr J. 2015 Jul 28;14:71. doi: 10.1186/s12937-015-0059-3. Review.

10.

Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.

Patel KR, Lawson DH, Kudchadkar RR, Carthon BC, Oliver DE, Okwan-Duodu D, Ahmed R, Khan MK.

Neuro Oncol. 2015 Oct;17(10):1312-21. doi: 10.1093/neuonc/nov093. Epub 2015 May 25. Review.

11.

Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation.

Jegadeesh N, Rajpara R, Esiashvili N, Shi Z, Liu Y, Okwan-Duodu D, Flowers CR, Khan MK.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):107-12. doi: 10.1016/j.ijrobp.2015.01.025.

12.

Total skin electron therapy for cutaneous T-cell lymphoma using a modern dual-field rotational technique.

Heumann TR, Esiashvili N, Parker S, Switchenko JM, Dhabbaan A, Goodman M, Lechowicz MJ, Flowers CR, Khan MK.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):183-91. doi: 10.1016/j.ijrobp.2014.11.033. Epub 2015 Feb 7. Erratum in: Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):729-30.

13.

Cancerogenesis Risks between 64 and 320 Row Detector CT for Coronary CTA Screening.

Khan AN, Khosa F, Nikolic B, Shuaib W, Lin PJ, Khan MK.

J Clin Imaging Sci. 2014 Apr 29;4:18. doi: 10.4103/2156-7514.131640. eCollection 2014.

14.

Respiratory-induced prostate motion using wavelet decomposition of the real-time electromagnetic tracking signal.

Lin Y, Liu T, Yang X, Wang Y, Khan MK.

Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):370-4. doi: 10.1016/j.ijrobp.2013.05.018. Epub 2013 Jul 18.

15.

The non-Gaussian nature of prostate motion based on real-time intrafraction tracking.

Lin Y, Liu T, Yang W, Yang X, Khan MK.

Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):363-9. doi: 10.1016/j.ijrobp.2013.05.019. Epub 2013 Jul 9.

16.

Dietary phytochemicals as potent chemotherapeutic agents against breast cancer: Inhibition of NF-κB pathway via molecular interactions in rel homology domain of its precursor protein p105.

Khan MK, Ansari IA, Khan MS.

Pharmacogn Mag. 2013 Jan;9(33):51-7. doi: 10.4103/0973-1296.108140. Erratum in: Pharmacogn Mag. 2013 Jul;9(35):282. Arif, Jamal [removed].

17.

Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.

Khan MK, Koyfman SA, Hunter GK, Reddy CA, Saxton JP.

Radiat Oncol. 2012 Nov 19;7:193. doi: 10.1186/1748-717X-7-193.

18.

Germinated brown rice as a value added rice product: A review.

Patil SB, Khan MK.

J Food Sci Technol. 2011 Dec;48(6):661-7. doi: 10.1007/s13197-011-0232-4. Epub 2011 Jan 22.

19.

Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy.

Platek ME, Reid ME, Wilding GE, Jaggernauth W, Rigual NR, Hicks WL Jr, Popat SR, Warren GW, Sullivan M, Thorstad WL, Khan MK, Loree TR, Singh AK.

Head Neck. 2011 Nov;33(11):1561-8. doi: 10.1002/hed.21640. Epub 2010 Dec 15.

20.

Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents.

Khan MK, Khan N, Almasan A, Macklis R.

Onco Targets Ther. 2011;4:137-48. doi: 10.2147/OTT.S20257. Epub 2011 Aug 9.

Supplemental Content

Loading ...
Support Center